Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 23

1.

Bone marrow B cell apoptosis during in vivo influenza virus infection requires TNF-alpha and lymphotoxin-alpha.

Sedger LM, Hou S, Osvath SR, Glaccum MB, Peschon JJ, van Rooijen N, Hyland L.

J Immunol. 2002 Dec 1;169(11):6193-201.

2.

Characterization of the in vivo function of TNF-alpha-related apoptosis-inducing ligand, TRAIL/Apo2L, using TRAIL/Apo2L gene-deficient mice.

Sedger LM, Glaccum MB, Schuh JC, Kanaly ST, Williamson E, Kayagaki N, Yun T, Smolak P, Le T, Goodwin R, Gliniak B.

Eur J Immunol. 2002 Aug;32(8):2246-54.

3.

RIP4 is an ankyrin repeat-containing kinase essential for keratinocyte differentiation.

Holland P, Willis C, Kanaly S, Glaccum M, Warren A, Charrier K, Murison J, Derry J, Virca G, Bird T, Peschon J.

Curr Biol. 2002 Aug 20;12(16):1424-8.

4.

A RANK/TRAF6-dependent signal transduction pathway is essential for osteoclast cytoskeletal organization and resorptive function.

Armstrong AP, Tometsko ME, Glaccum M, Sutherland CL, Cosman D, Dougall WC.

J Biol Chem. 2002 Nov 15;277(46):44347-56. Epub 2002 Aug 15.

5.

Cytokine requirements for acute and Basal homeostatic proliferation of naive and memory CD8+ T cells.

Goldrath AW, Sivakumar PV, Glaccum M, Kennedy MK, Bevan MJ, Benoist C, Mathis D, Butz EA.

J Exp Med. 2002 Jun 17;195(12):1515-22.

6.

Increased susceptibility to tumor initiation and metastasis in TNF-related apoptosis-inducing ligand-deficient mice.

Cretney E, Takeda K, Yagita H, Glaccum M, Peschon JJ, Smyth MJ.

J Immunol. 2002 Feb 1;168(3):1356-61.

7.

Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice.

Kennedy MK, Glaccum M, Brown SN, Butz EA, Viney JL, Embers M, Matsuki N, Charrier K, Sedger L, Willis CR, Brasel K, Morrissey PJ, Stocking K, Schuh JC, Joyce S, Peschon JJ.

J Exp Med. 2000 Mar 6;191(5):771-80.

8.

RANK is essential for osteoclast and lymph node development.

Dougall WC, Glaccum M, Charrier K, Rohrbach K, Brasel K, De Smedt T, Daro E, Smith J, Tometsko ME, Maliszewski CR, Armstrong A, Shen V, Bain S, Cosman D, Anderson D, Morrissey PJ, Peschon JJ, Schuh J.

Genes Dev. 1999 Sep 15;13(18):2412-24.

9.

Mice lacking the type I interleukin-1 receptor do not lose bone mass after ovariectomy.

Lorenzo JA, Naprta A, Rao Y, Alander C, Glaccum M, Widmer M, Gronowicz G, Kalinowski J, Pilbeam CC.

Endocrinology. 1998 Jun;139(6):3022-5.

PMID:
9607815
10.

TNF receptor-deficient mice reveal divergent roles for p55 and p75 in several models of inflammation.

Peschon JJ, Torrance DS, Stocking KL, Glaccum MB, Otten C, Willis CR, Charrier K, Morrissey PJ, Ware CB, Mohler KM.

J Immunol. 1998 Jan 15;160(2):943-52.

11.

Phenotypic and functional characterization of mice that lack the type I receptor for IL-1.

Glaccum MB, Stocking KL, Charrier K, Smith JL, Willis CR, Maliszewski C, Livingston DJ, Peschon JJ, Morrissey PJ.

J Immunol. 1997 Oct 1;159(7):3364-71.

PMID:
9317135
12.

Altered acute phase responses to inflammation in IL-1 and TNF receptor knockout mice.

Leon LR, Kozak W, Peschon J, Glaccum M, Kluger MJ.

Ann N Y Acad Sci. 1997 Mar 15;813:244-54. No abstract available.

PMID:
9100890
13.

IL-1 type I receptor mediates acute phase response to turpentine, but not lipopolysaccharide, in mice.

Leon LR, Conn CA, Glaccum M, Kluger MJ.

Am J Physiol. 1996 Dec;271(6 Pt 2):R1668-75.

PMID:
8997368
14.

Interleukin-6 expression and histomorphometry of bones from mice deficient in receptors for interleukin-1 or tumor necrosis factor.

Vargas SJ, Naprta A, Glaccum M, Lee SK, Kalinowski J, Lorenzo JA.

J Bone Miner Res. 1996 Nov;11(11):1736-44.

PMID:
8915781
15.

Active interleukin-1 receptor required for maximal progression of acute pancreatitis.

Norman JG, Fink G, Franz M, Guffey J, Carter G, Davison B, Sexton C, Glaccum M.

Ann Surg. 1996 Feb;223(2):163-9.

16.

Chromosomal assignment and genomic structure of Il15.

Anderson DM, Johnson L, Glaccum MB, Copeland NG, Gilbert DJ, Jenkins NA, Valentine V, Kirstein MN, Shapiro DN, Morris SW, et al.

Genomics. 1995 Feb 10;25(3):701-6.

PMID:
7759105
17.
18.

Naltrindole, an opioid delta receptor antagonist, blocks cocaine-induced facilitation of responding for rewarding brain stimulation.

Reid LD, Hubbell CL, Glaccum MB, Bilsky EJ, Portoghese PS, Porreca F.

Life Sci. 1993;52(9):PL67-71.

PMID:
8382329
19.

Isolation of the cDNA encoding rat skeletal muscle myosin light chain kinase. Sequence and tissue distribution.

Roush CL, Kennelly PJ, Glaccum MB, Helfman DM, Scott JD, Krebs EG.

J Biol Chem. 1988 Jul 25;263(21):10510-6.

20.

The molecular cloning of a type II regulatory subunit of the cAMP-dependent protein kinase from rat skeletal muscle and mouse brain.

Scott JD, Glaccum MB, Zoller MJ, Uhler MD, Helfman DM, McKnight GS, Krebs EG.

Proc Natl Acad Sci U S A. 1987 Aug;84(15):5192-6.

21.

Primary-structure requirements for inhibition by the heat-stable inhibitor of the cAMP-dependent protein kinase.

Scott JD, Glaccum MB, Fischer EH, Krebs EG.

Proc Natl Acad Sci U S A. 1986 Mar;83(6):1613-6.

22.

In vitro analysis of Hin-mediated site-specific recombination.

Johnson RC, Bruist MB, Glaccum MB, Simon MI.

Cold Spring Harb Symp Quant Biol. 1984;49:751-60. No abstract available.

PMID:
6099257
23.

Light isomerizes the chromophore of bacteriorhodopsin.

Tsuda M, Glaccum M, Nelson B, Ebrey TG.

Nature. 1980 Sep 25;287(5780):351-3.

PMID:
7421996

Supplemental Content

Loading ...
Support Center